Results 291 to 300 of about 92,879 (318)
Some of the next articles are maybe not open access.
The Role of the Fluoroquinolones
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1992Over the past decade, the quinolone antimicrobial class has enjoyed a renaissance with the emergence of the fluoroquinolone subclass. Norfloxacin, ciprofloxacin, ofloxacin, enoxacin, and lomefloxacin have the advantages of broad antimicrobial activity profiles including gram‐positive and ‐negative aerobes, favorable pharmacokinetic profiles including ...
openaire +3 more sources
Safety of fluoroquinolones in paediatrics
Expert Opinion on Drug Safety, 2002In the last few years, there has been increasing pressure to use fluoroquinolones in paediatric patients, since these antibiotics offer the advantage of an oral treatment regimen on an out-patient basis. However, even although this class of antibiotics generally remains well-tolerated, the restriction of fluoroquinolone use in children on a ...
Cuzzolin L, FANOS, VASSILIOS
openaire +5 more sources
Fluoroquinolones in the treatment of meningitis
Current Infectious Disease Reports, 2003The continuous increase of resistant pathogens causing meningitis has limited the efficacy of standard therapeutic regimens. Due to their excellent activity in vitro and their good penetration into the cerebrospinal fluid (CSF), fluoroquinolones appear promising for the treatment of meningitis caused by gram-negative microorganisms, ie, Neisseria ...
Martin G. Täuber, Philippe Cottagnoud
openaire +3 more sources
Seizures Associated with Fluoroquinolones
The Annals of Pharmacotherapy, 2001OBJECTIVE: To report two cases of seizures following administration of levofloxacin and ciprofloxacin. CASE SUMMARY: A 75-year-old white woman admitted to the hospital was prescribed levofloxacin for ischemic toes. After receiving three doses of oral levofloxacin, the patient experienced a seizure.
Janine M Kushner+2 more
openaire +3 more sources
Drug and Therapeutics Bulletin, 1994
Two fluoroquinolone antibiotics, ciprofloxacin (Ciloxan - Alcon) and ofloxacin (Exocin - Allergan), are available in the UK as topical preparations for the eye.* Ciprofloxacin eyedrops are licensed for the treatment of "corneal ulcers and superficial infections of the eye", and ofloxacin eyedrops for "external ocular infections (such as conjunctivitis ...
openaire +2 more sources
Two fluoroquinolone antibiotics, ciprofloxacin (Ciloxan - Alcon) and ofloxacin (Exocin - Allergan), are available in the UK as topical preparations for the eye.* Ciprofloxacin eyedrops are licensed for the treatment of "corneal ulcers and superficial infections of the eye", and ofloxacin eyedrops for "external ocular infections (such as conjunctivitis ...
openaire +2 more sources
Drugs, 1995
The main types of adverse effects associated with quinolones are uncommon and reversible and vary in frequency among different agents. Phototoxicity appears more frequent with lomefloxacin than with some other quinolones. Three mechanisms have been proposed to explain the neurotoxic effects, including rare proconvulsant activity, associated with ...
openaire +3 more sources
The main types of adverse effects associated with quinolones are uncommon and reversible and vary in frequency among different agents. Phototoxicity appears more frequent with lomefloxacin than with some other quinolones. Three mechanisms have been proposed to explain the neurotoxic effects, including rare proconvulsant activity, associated with ...
openaire +3 more sources
Journal of the American Academy of Orthopaedic Surgeons, 2002
Alan M, Levine, John R, DiBona
openaire +2 more sources
Alan M, Levine, John R, DiBona
openaire +2 more sources
Fluoroquinolones and the risk of tendon injury: a systematic review and meta-analysis
European Journal of Clinical Pharmacology, 2019C. Alves, D. Mendes, F. Marques
semanticscholar +1 more source
Adverse Effects of the Fluoroquinolones
Clinical Infectious Diseases, 1988Data on adverse reactions due to the quinolone antibacterial agents--ciprofloxacin, ofloxacin, pefloxacin, norfloxacin, and enoxacin--observed in a patient sample of approximately 30,000 are reviewed. Overall rates of adverse reactions were 4.0%-8.0%, and adverse reactions necessitated discontinuation of therapy in 1.0%-2.6% of patients.
openaire +3 more sources